← FDA Drug Approvals (Drugs@FDA)
EPLERENONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2017-07-13
Drug application
- FDA Application #
ANDA206922
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPLERENONE
- Generic name
- EPLERENONE
- Active ingredients
- EPLERENONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ACCORD HLTHCARE
- Manufacturer
- Accord Healthcare, Inc.
- First approval
- 2017-07-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown